Study Maps Economic Fallout of NIH Cuts in Georgia

The Science & Community Impacts Mapping Project (SCIMaP) shows how proposed federal funding cuts lead to reduced economic activity and job losses nationwide.

Georgia faces severe economic consequences as the Trump administration plans significant cuts to indirect funding by the National Institutes of Health (NIH). According to the Science & Community Impacts Mapping Project, Georgia stands to lose approximately $327 million in funding and 1,414 jobs, with effects rippling through communities across the state. 

 

Georgia's projected $327 million loss is part of a broader national impact. According to the project's findings, nearly half of all U.S. counties will experience economic losses of at least $250,000, with more than 500 counties losing over $6.25 million in funding. 

 

Ripple Effects on Innovation and Healthcare 

Beyond immediate economic losses, the cuts threaten Georgia's position in biomedical innovation. The state has historically leveraged NIH funding to: 


  • Develop groundbreaking medical treatments
  • Establish biotechnology startups
  • Train the next generation of healthcare professionals and researchers
  • Address critical public health challenges 


The proposed cuts would affect not only our state's major research universities but also regional institutions and the communities they support throughout the state. For communities already facing economic challenges, the loss of research-related economic activity could exacerbate existing problems. 

 

Looking Forward 

The Science & Community Impacts Mapping Project provides a sobering look at what's at stake for Georgia's communities when research funding diminishes, highlighting how federal research investment creates economic value far beyond laboratory walls. 

March 17, 2026
Georgia Life Sciences leads effort to establish bipartisan caucus focused on advancing the state’s growing life sciences economy
March 13, 2026
A skilled workforce is the engine that will drive growth across America’s biotechnology industry, and Atlanta has built multi-faceted training programs that are developing and sustaining the talent pipeline for everything from advanced laboratory research to industrial biomanufacturing.
March 12, 2026
On March 12, 2026, Augusta, Georgia served as the setting for an important conversation about the future of American biotechnology and manufacturing. Manus welcomed members of the U.S. National Security Commission on Emerging Biotechnology (NSCEB) to its Augusta BioFacility to highlight how advanced biomanufacturing is strengthening U.S. supply chain resilience and supporting the growing bioeconomy. During the visit, Manus unveiled a significant expansion of its 44-acre Augusta BioFacility, increasing domestic capacity to produce critical biobased ingredients. The expansion further positions Georgia as a key hub for advanced biomanufacturing and demonstrates the growing role of biotechnology in strengthening national economic and supply chain security. Commission members met with leaders from industry, government, and academia to discuss strategies for scaling manufacturing infrastructure, strengthening resilient supply chains, and preparing the workforce needed to support the next generation of the U.S. bioeconomy. The visit also included conversations with Manus employees about the practical realities of building and operating advanced biomanufacturing facilities in the United States. The Augusta site has become one of the largest advanced biomanufacturing facilities in the country, producing a growing portfolio of bioalternatives at industrial scale. Among these products is high-purity Reb M, recently launched as Yume™ M Stevia Sweetener , supported by an all-Americas supply chain. “As we scale the Manus bioalternatives platform, Augusta has become a powerful example of what the modern U.S. bioeconomy looks like in practice,” said Manus Founder and CEO Ajikumar Parayil. The visit underscores Georgia’s expanding leadership in life sciences manufacturing and highlights how regional ecosystems can help advance U.S. leadership in biotechnology and biomanufacturing. Learn more about the expansion and visit: Manus welcomes U.S. National Security Commission on Emerging Biotechnology to unveil major Augusta BioFacility expansion Growing Georgia Biomanufacturing Industry Transforming American Industrial Strength
MORE POSTS